Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

Back to Acute Lung Injury

Acute Lung Injury — NIH Grants & Funding

Active and recent NIH-funded research on Acute Lung Injury. Data from NIH RePORTER, last 36 months.

MONDO:0015796

NIH-funded research on Acute Lung Injury

active grants

institutions

140

researchers

new in last 12 mo.

$131.9M in NIH funding over the last 36 months. Data from NIH RePORTER.

I'm looking for:

Or filter by research focus

Only show active grants

Basic Science(101)

Basic ScienceP01Completed

Macrophage Plasticity in Inflammatory Lung Injury

MEHTA, DOLLY·UNIVERSITY OF ILLINOIS AT CHICAGO·Chicago, IL

$2,396,443 (FY2025)

Acute Lung Injury — NIH Grants & Funding

Basic Science(101)

Macrophage Plasticity in Inflammatory Lung Injury

The Lung Endothelium as an Instructive Niche for the Innate Immune System during Vascular Injury

Mast Cell Activation as a Common Mechanism of Pulmonary Toxicity by Chemical Threat Agents

Aerosolized Chemically Modified Tetracycline Nanoformulation for the Treatment of Acute Respiratory Distress Syndrome

Immunobiology of the normal and injured lung

Chemokine receptor signaling and the dynamics of neutrophil phenotypes during inflammatory lung injury

Identifying Novel Roles and the Therapeutic Potential of the Thrombin Receptor Protease Activated Receptor-1 (PAR1) in Lung Lymphatic Function and Acute Respiratory Distress Syndrome

Induction of myeloid-epithelial gap junctional channels to enhance host resilience against acute lung injury.

Intravenously injected mesenchymal stromal cells protect against Acute Lung Injury by transferring mitochondria to restore endothelial function

The effect of endogenous and exogenous glucocorticoids acting through regulatory T cells on resolution of ALI and the contribution of host genetic variability.

Translational(17)

Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a

Novel therapeutic approach for severe ARDS with a potent pharmacologic allosteric hemoglobin modifier

Targeting mechanisms activating ion-channel for preventing acute lung injury

Development of Novel RhoA Nitration Inhibitory Peptides for the Treatment of Acute Lung Injury

Targeted mRNA therapies treating ARDS

Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury

Medical countermeasures to chlorine exposure based on GABA(A) receptor targeting

A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)

A multimodal delivery and treatment approach for Acute Lung Injury

Immunotherapy for acute lung injury secondary to influenza

Clinical(8)

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

Targeted treatment of acute lung injury using isolated lung perfusion

IL-33 induced-lL-9 producing type 2 innate lymphoid cells in the regulation of acute lung injury after hematopoietic stem cell transplantation (HSCT) in pediatric patients

Peri-operative factors that drive cell-free hemoglobin-mediated primary graft dysfunction

The Clinical and Molecular Impacts of Lung Primary Graft Dysfunction

Transfer RNAs as novel mediators in acute lung injury

Immunosuppression in Acute Lung Injury

Patient-Oriented Research in Acute Lung Injury and Host Defense in the ICU

Epi / Nat. History(2)

Impact of Diet Induced Obesity on Acute Lung Injury

Impact of Diet Induced Obesity on Acute Lung Injury

Gene/Cell Therapy(1)

Modulating signaling pathways in alveolar epithelial cells with engineered T cells

Biomarker / Dx(2)

Incorporating Donor Lung CT Images into Machine Learning Models to Predict Severe Primary Graft Dysfunction after Lung Transplantation

CMKLR1-Targeted Molecular Imaging of Inflammation as a Precision Medicine Tool in Acute Lung Injury and Fibrotic Lung Diseases

Other(5)

Role of Macrophage Efferocytosis in Ozone-Induced ARDS

Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a

Netosis in Trauma Mediated Acute Lung Injury

Tissue-specific functional genomics in the acute respiratory distress syndrome

Pulmonary Disfunction after Polysubstance Exposure: Mechanistic Identification of Inflammatory Mediators